Literature DB >> 1865526

Thrombocytopenia during interferon alfa therapy.

J H Hoofnagle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1865526     DOI： 10.1001/jama.266.6.849

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.

Authors:  Abdurrahman Sagir; Matthias Wettstein; Tobias Heintges; Dieter Häussinger
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.

Authors:  A H Lashin; Y A Shaheen; M A Metwally; H M El-Feky; M F Hegab; S M Abbas
Journal:  Indian J Gastroenterol       Date:  2013-05-29

3.  Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.

Authors:  J Cianciara; T Laskus
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

4.  Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.

Authors:  M Schmid; A Kreil; W Jessner; M Homoncik; C Datz; A Gangl; P Ferenci; M Peck-Radosavljevic
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 5.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

6.  Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.

Authors:  Tomohiko Akahoshi; Morimasa Tomikawa; Daisuke Korenaga; Koji Ikejiri; Motonori Saku; Kenji Takenaka
Journal:  Surg Endosc       Date:  2009-08-19       Impact factor: 4.584

7.  Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.

Authors:  Kent W Kercher; Alfredo M Carbonell; B Todd Heniford; Brent D Matthews; Dawn M Cunningham; Robert W Reindollar
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

8.  Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.

Authors:  Weimin Jiang; Hisashi Hidaka; Takahide Nakazawa; Hiroyuki Kitagawa; Wasaburo Koizumi
Journal:  BMC Res Notes       Date:  2014-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.